| GE Healthcare AG - Accupaque 300 mg I/ml, Injektionslösung |
| 54637 | | 01 | | Accupaque 300 mg I/ml | | Injektionslösung | | V08AB02 | | Iohexol | | 24.08.1998 | | |
|
| Composition |
| iohexolum 647 mg corresp. iodum 300 mg, trometamolum, natrii calcii edetas corresp. natrium 12 µg, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Iohexol | 647 mg/ml correspond Iod 300 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Iohexol | 647 mg |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum ad Ph | | Sodium Calcium Edetate | | Trometamol |
| |
|
|
